1
|
Kolberg-Edelbrock J, Cotey TJ, Ma SY, Kapsalis LM, Bondoc DM, Lee SR, Sai H, Smith CS, Chen F, Kolberg-Edelbrock AN, Strong ME, Stupp SI. Biomimetic Extracellular Scaffolds by Microfluidic Superstructuring of Nanofibers. ACS Biomater Sci Eng 2023; 9:1251-1260. [PMID: 36808976 DOI: 10.1021/acsbiomaterials.2c01098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Abstract
The extracellular matrix is a dynamic framework bearing chemical and morphological cues that support many cellular functions, and artificial analogs with well-defined chemistry are of great interest for biomedical applications. Herein, we describe hierarchical, extracellular-matrix-mimetic microgels, termed "superbundles" (SBs) composed of peptide amphiphile (PA) supramolecular nanofiber networks created using flow-focusing microfluidic devices. We explore the effects of altered flow rate ratio and PA concentration on the ability to create SBs and develop design rules for producing SBs with both cationic and anionic PA nanofibers and gelators. We demonstrate the morphological similarities of SBs to decellularized extracellular matrices and showcase their ability to encapsulate and retain proteinaceous cargos with a wide variety of isoelectric points. Finally, we demonstrate that the novel SB morphology does not affect the well-established biocompatibility of PA gels.
Collapse
Affiliation(s)
- Jack Kolberg-Edelbrock
- Department of Materials Science and Engineering, McCormick School of Engineering, Northwestern University, 2220 Campus Drive, Room 2036, Evanston, Illinois 60208-0893, United States
- Medical Scientist Training Program, Feinberg School of Medicine, Northwestern University, 303 East Chicago Avenue, Morton 1-670, Chicago, Illinois 60611-3008, United States
| | - Thomas J Cotey
- Department of Materials Science and Engineering, McCormick School of Engineering, Northwestern University, 2220 Campus Drive, Room 2036, Evanston, Illinois 60208-0893, United States
| | - Steven Y Ma
- Department of Materials Science and Engineering, McCormick School of Engineering, Northwestern University, 2220 Campus Drive, Room 2036, Evanston, Illinois 60208-0893, United States
| | - Litsa M Kapsalis
- Department of Materials Science and Engineering, McCormick School of Engineering, Northwestern University, 2220 Campus Drive, Room 2036, Evanston, Illinois 60208-0893, United States
| | - Delaney M Bondoc
- Department of Chemistry, Weinberg College of Arts and Sciences, Northwestern University, 2145 Sheridan Road, Tech K148, Evanston, Illinois 60208-0834, United States
| | - Sieun Ruth Lee
- Department of Materials Science and Engineering, McCormick School of Engineering, Northwestern University, 2220 Campus Drive, Room 2036, Evanston, Illinois 60208-0893, United States
| | - Hiroaki Sai
- Department of Materials Science and Engineering, McCormick School of Engineering, Northwestern University, 2220 Campus Drive, Room 2036, Evanston, Illinois 60208-0893, United States
- Simpson Querrey Institute for BioNanotechnology, Northwestern University, 303 East Superior Street, Lurie 11, Chicago, Illinois 60611-3015, United States
| | - Cara S Smith
- Department of Biomedical Engineering, McCormick School of Engineering, Northwestern University, 2145 Sheridan Road, Tech E310, Evanston, Illinois 60208-0893, United States
| | - Feng Chen
- Simpson Querrey Institute for BioNanotechnology, Northwestern University, 303 East Superior Street, Lurie 11, Chicago, Illinois 60611-3015, United States
| | - Alexandra N Kolberg-Edelbrock
- Department of Biomedical Engineering, McCormick School of Engineering, Northwestern University, 2145 Sheridan Road, Tech E310, Evanston, Illinois 60208-0893, United States
| | - Madison E Strong
- Department of Biomedical Engineering, McCormick School of Engineering, Northwestern University, 2145 Sheridan Road, Tech E310, Evanston, Illinois 60208-0893, United States
| | - Samuel I Stupp
- Department of Materials Science and Engineering, McCormick School of Engineering, Northwestern University, 2220 Campus Drive, Room 2036, Evanston, Illinois 60208-0893, United States
- Department of Chemistry, Weinberg College of Arts and Sciences, Northwestern University, 2145 Sheridan Road, Tech K148, Evanston, Illinois 60208-0834, United States
- Simpson Querrey Institute for BioNanotechnology, Northwestern University, 303 East Superior Street, Lurie 11, Chicago, Illinois 60611-3015, United States
- Department of Biomedical Engineering, McCormick School of Engineering, Northwestern University, 2145 Sheridan Road, Tech E310, Evanston, Illinois 60208-0893, United States
- Department of Medicine, Feinberg School of Medicine, Northwestern University, 676 North Saint Clair Street, Arkes Suite 2330, Chicago, Illinois 60611-2915, United States
| |
Collapse
|
2
|
Yu M, Lin S, Ge R, Xiong C, Xu L, Zhao M, Fan J. Buckwheat self-assembling peptide-based hydrogel: Preparation, characteristics and forming mechanism. Food Hydrocoll 2022. [DOI: 10.1016/j.foodhyd.2021.107378] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
3
|
Multifunctional building elements for the construction of peptide drug conjugates. ENGINEERED REGENERATION 2022. [DOI: 10.1016/j.engreg.2022.02.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
|
4
|
Chen S, Yang L, Leung FKC, Kajitani T, Stuart MCA, Fukushima T, van Rijn P, Feringa BL. Photoactuating Artificial Muscles of Motor Amphiphiles as an Extracellular Matrix Mimetic Scaffold for Mesenchymal Stem Cells. J Am Chem Soc 2022; 144:3543-3553. [PMID: 35171583 PMCID: PMC8895399 DOI: 10.1021/jacs.1c12318] [Citation(s) in RCA: 24] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
![]()
Mimicking the native
extracellular matrix (ECM) as a cell culture
scaffold has long attracted scientists from the perspective of supramolecular
chemistry for potential application in regenerative medicine. However,
the development of the next-generation synthetic materials that mimic
key aspects of ECM, with hierarchically oriented supramolecular structures,
which are simultaneously highly dynamic and responsive to external
stimuli, remains a major challenge. Herein, we present supramolecular
assemblies formed by motor amphiphiles (MAs), which mimic
the structural features of the hydrogel nature of the ECM and additionally
show intrinsic dynamic behavior that allow amplifying molecular motions
to macroscopic muscle-like actuating functions induced by light. The
supramolecular assembly (named artificial muscle) provides an attractive
approach for developing responsive ECM mimetic scaffolds for human
bone marrow-derived mesenchymal stem cells (hBM-MSCs).
Detailed investigations on the photoisomerization by nuclear magnetic
resonance and UV–vis absorption spectroscopy, assembled structures
by electron microscopy, the photoactuation process, structural order
by X-ray diffraction, and cytotoxicity are presented. Artificial muscles
of MAs provide fast photoactuation in water based on
the hierarchically anisotropic supramolecular structures and show
no cytotoxicity. Particularly important, artificial muscles of MAs with adhered hBM-MSCs still can be actuated
by external light stimulation, showing their ability to convert light
energy into mechanical signals in biocompatible systems. As a proof-of-concept
demonstration, these results provide the potential for building photoactuating
ECM mimetic scaffolds by artificial muscle-like supramolecular assemblies
based on MAs and offer opportunities for signal transduction
in future biohybrid systems of cells and MAs.
Collapse
Affiliation(s)
- Shaoyu Chen
- Center for System Chemistry, Stratingh Institute for Chemistry, University of Groningen, AG Groningen 9747, The Netherlands.,Key Laboratory for Advanced Materials and Joint International Research Laboratory of Precision Chemistry and Molecular Engineering, Feringa Nobel Prize Scientist Joint Research Center, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Institute of Fine Chemicals, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, China
| | - Liangliang Yang
- Department of Biomedical Engineering, University Medical Center Groningen, University of Groningen, AV Groningen 9713, The Netherlands
| | - Franco King-Chi Leung
- Center for System Chemistry, Stratingh Institute for Chemistry, University of Groningen, AG Groningen 9747, The Netherlands
| | - Takashi Kajitani
- Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsuta, Midori-ku, Yokohama 226-8503, Japan
| | - Marc C A Stuart
- Center for System Chemistry, Stratingh Institute for Chemistry, University of Groningen, AG Groningen 9747, The Netherlands
| | - Takanori Fukushima
- Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsuta, Midori-ku, Yokohama 226-8503, Japan
| | - Patrick van Rijn
- Department of Biomedical Engineering, University Medical Center Groningen, University of Groningen, AV Groningen 9713, The Netherlands
| | - Ben L Feringa
- Center for System Chemistry, Stratingh Institute for Chemistry, University of Groningen, AG Groningen 9747, The Netherlands.,Key Laboratory for Advanced Materials and Joint International Research Laboratory of Precision Chemistry and Molecular Engineering, Feringa Nobel Prize Scientist Joint Research Center, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Institute of Fine Chemicals, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, China
| |
Collapse
|
5
|
Peters EB, Karver MR, Sun K, Gillis DC, Biswas S, Clemons TD, He W, Tsihlis ND, Stupp SI, Kibbe MR. Self-Assembled Peptide Amphiphile Nanofibers for Controlled Therapeutic Delivery to the Atherosclerotic Niche. ADVANCED THERAPEUTICS 2021; 4:2100103. [PMID: 34926792 PMCID: PMC8680456 DOI: 10.1002/adtp.202100103] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2021] [Indexed: 11/08/2022]
Abstract
Atherosclerotic plaque remains the leading contributor to cardiovascular disease and requires invasive surgical procedures for its removal. Nanomedicine offers a minimally invasive approach to alleviate plaque burden by targeted therapeutic delivery. However, nanocarriers are limited without the ability to sense and respond to the diseased microenvironment. In this study, targeted self-assembled peptide amphiphile (PA) nanofibers were developed that cleave in response to biochemical cues expressed in atherosclerotic lesions-reactive oxygen species (ROS) and intracellular glutathione-to deliver a liver X receptor agonist (LXR) to enhance macrophage cholesterol efflux. The PAs released LXR in response to physiological levels of ROS and reducing agents and could be co-assembled with plaque-targeting PAs to form nanofibers. The resulting LXR PA nanofibers promoted cholesterol efflux from macrophages in vitro as well as LXR alone and with lower cytotoxicity. Further, the ApoA1-LXR PA nanofibers targeted plaque within an atherosclerotic mouse model in vivo and activated ATP-binding cassette A1 (ABCA1) expression as well as LXR alone with reduced liver toxicity. Taken together, these results demonstrate the potential of self-assembled PA nanofibers for controlled therapeutic delivery to the atherosclerotic niche.
Collapse
Affiliation(s)
- Erica B. Peters
- Department of Surgery, Division of Vascular Surgery and Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Mark R. Karver
- Simpson Querrey Institute, Northwestern University, Chicago, IL 60611, USA
| | - Kui Sun
- Department of Surgery, Division of Vascular Surgery and Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - David C. Gillis
- Department of Surgery, Division of Vascular Surgery and Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Suvendu Biswas
- Simpson Querrey Institute, Northwestern University, Chicago, IL 60611, USA
| | - Tristan D. Clemons
- Simpson Querrey Institute, Northwestern University, Chicago, IL 60611, USA
- Department of Chemistry, Northwestern University, Evanston, IL 60208, USA
| | - Wenhan He
- Department of Surgery, Division of Vascular Surgery and Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Nick D. Tsihlis
- Department of Surgery, Division of Vascular Surgery and Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Samuel I. Stupp
- Simpson Querrey Institute, Northwestern University, Chicago, IL 60611, USA
- Department of Chemistry, Northwestern University, Evanston, IL 60208, USA
- Department of Materials Science & Engineering and Department of Biomedical Engineering, Northwestern University, Evanston, IL 60208, USA
- Department of Medicine, Northwestern University, Chicago, IL 60611, USA
| | - Melina R. Kibbe
- Department of Surgery, Division of Vascular Surgery and Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
- Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| |
Collapse
|
6
|
Marulanda K, Mercel A, Gillis DC, Sun K, Gambarian M, Roark J, Weiss J, Tsihlis ND, Karver MR, Centeno SR, Peters EB, Clemons TD, Stupp SI, McLean SE, Kibbe MR. Intravenous Delivery of Lung-Targeted Nanofibers for Pulmonary Hypertension in Mice. Adv Healthc Mater 2021; 10:e2100302. [PMID: 34061473 PMCID: PMC8273153 DOI: 10.1002/adhm.202100302] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2021] [Revised: 03/15/2021] [Indexed: 01/11/2023]
Abstract
Pulmonary hypertension is a highly morbid disease with no cure. Available treatments are limited by systemic adverse effects due to non-specific biodistribution. Self-assembled peptide amphiphile (PA) nanofibers are biocompatible nanomaterials that can be modified to recognize specific biological markers to provide targeted drug delivery and reduce off-target toxicity. Here, PA nanofibers that target the angiotensin I-converting enzyme and the receptor for advanced glycation end-products (RAGE) are developed, as both proteins are overexpressed in the lung with pulmonary hypertension. It is demonstrated that intravenous delivery of RAGE-targeted nanofibers containing the targeting epitope LVFFAED (LVFF) significantly accumulated within the lung in a chronic hypoxia-induced pulmonary hypertension mouse model. Using 3D light sheet fluorescence microscopy, it is shown that LVFF nanofiber localization is specific to the diseased pulmonary tissue with immunofluorescence analysis demonstrating colocalization of the targeted nanofiber to RAGE in the hypoxic lung. Furthermore, biodistribution studies show that significantly more LVFF nanofibers localized to the lung compared to major off-target organs. Targeted nanofibers are retained within the pulmonary tissue for 24 h after injection. Collectively, these data demonstrate the potential of a RAGE-targeted nanomaterial as a drug delivery platform to treat pulmonary hypertension.
Collapse
Affiliation(s)
- Kathleen Marulanda
- Department of Surgery, University of North Carolina, 4041 Burnett Womack, 101 Manning Drive, Chapel Hill, NC, 27599, USA
| | - Alexandra Mercel
- Department of Surgery, University of North Carolina, 4041 Burnett Womack, 101 Manning Drive, Chapel Hill, NC, 27599, USA
| | - David C Gillis
- Department of Surgery, University of North Carolina, 4041 Burnett Womack, 101 Manning Drive, Chapel Hill, NC, 27599, USA
| | - Kui Sun
- Department of Surgery, University of North Carolina, 4041 Burnett Womack, 101 Manning Drive, Chapel Hill, NC, 27599, USA
| | - Maria Gambarian
- Department of Surgery, University of North Carolina, 4041 Burnett Womack, 101 Manning Drive, Chapel Hill, NC, 27599, USA
| | - Joshua Roark
- Department of Surgery, University of North Carolina, 4041 Burnett Womack, 101 Manning Drive, Chapel Hill, NC, 27599, USA
| | - Jenna Weiss
- Department of Surgery, University of North Carolina, 4041 Burnett Womack, 101 Manning Drive, Chapel Hill, NC, 27599, USA
| | - Nick D Tsihlis
- Department of Surgery, University of North Carolina, 4041 Burnett Womack, 101 Manning Drive, Chapel Hill, NC, 27599, USA
| | - Mark R Karver
- Simpson Querrey Institute, Northwestern University, 303 E. Superior Street, Chicago, IL, 60611, USA
| | - S Ruben Centeno
- Department of Pediatrics, University of North Carolina, 260 MacNider Building CB# 7220, Chapel Hill, NC, 27599, USA
| | - Erica B Peters
- Department of Surgery, University of North Carolina, 4041 Burnett Womack, 101 Manning Drive, Chapel Hill, NC, 27599, USA
| | - Tristan D Clemons
- Simpson Querrey Institute, Northwestern University, 303 E. Superior Street, Chicago, IL, 60611, USA
| | - Samuel I Stupp
- Simpson Querrey Institute, Northwestern University, 303 E. Superior Street, Chicago, IL, 60611, USA
| | - Sean E McLean
- Department of Surgery, University of North Carolina, 4041 Burnett Womack, 101 Manning Drive, Chapel Hill, NC, 27599, USA
| | - Melina R Kibbe
- Department of Surgery, University of North Carolina, 4041 Burnett Womack, 101 Manning Drive, Chapel Hill, NC, 27599, USA
| |
Collapse
|
7
|
Sharma P, Pal VK, Roy S. An overview of latest advances in exploring bioactive peptide hydrogels for neural tissue engineering. Biomater Sci 2021; 9:3911-3938. [PMID: 33973582 DOI: 10.1039/d0bm02049d] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Neural tissue engineering holds great potential in addressing current challenges faced by medical therapies employed for the functional recovery of the brain. In this context, self-assembling peptides have gained considerable interest owing to their diverse physicochemical properties, which enable them to closely mimic the biophysical characteristics of the native ECM. Additionally, in contrast to synthetic polymers, which lack inherent biological signaling, peptide-based nanomaterials could be easily designed to present essential biological cues to the cells to promote cellular adhesion. Moreover, injectability of these biomaterials further widens their scope in biomedicine. In this context, hydrogels obtained from short bioactive peptide sequences are of particular interest owing to their facile synthesis and highly tunable properties. In spite of their well-known advantages, the exploration of short peptides for neural tissue engineering is still in its infancy and thus detailed discussion is required to evoke interest in this direction. This review provides a general overview of various bioactive hydrogels derived from short peptide sequences explored for neural tissue engineering. The review also discusses the current challenges in translating the benefits of these hydrogels to clinical practices and presents future perspectives regarding the utilization of these hydrogels for advanced biomedical applications.
Collapse
Affiliation(s)
- Pooja Sharma
- Institute of Nano Science and Technology, Sector 81, Knowledge city, Mohali, 140306, Punjab, India.
| | - Vijay Kumar Pal
- Institute of Nano Science and Technology, Sector 81, Knowledge city, Mohali, 140306, Punjab, India.
| | - Sangita Roy
- Institute of Nano Science and Technology, Sector 81, Knowledge city, Mohali, 140306, Punjab, India.
| |
Collapse
|
8
|
Mougin J, Bourgaux C, Couvreur P. Elongated self-assembled nanocarriers: From molecular organization to therapeutic applications. Adv Drug Deliv Rev 2021; 172:127-147. [PMID: 33705872 DOI: 10.1016/j.addr.2021.02.018] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2020] [Revised: 12/18/2020] [Accepted: 02/26/2021] [Indexed: 12/31/2022]
Abstract
Self-assembled cylindrical aggregates made of amphiphilic molecules emerged almost 40 years ago. Due to their length up to micrometers, those particles display original physico-chemical properties such as important flexibility and, for concentrated samples, a high viscoelasticity making them suitable for a wide range of industrial applications. However, a quarter of century was needed to successfully take advantage of those improvements towards therapeutic purposes. Since then, a wide diversity of biocompatible materials such as polymers, lipids or peptides, have been developed to design self-assembling elongated drug nanocarriers, suitable for therapeutic or diagnostic applications. More recently, the investigation of the main forces driving the unidirectional growth of these nanodevices allowed a translation toward the formation of pure nanodrugs to avoid the use of unnecessary side materials and the possible toxicity concerns associated.
Collapse
Affiliation(s)
- Julie Mougin
- Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 92296 Châtenay-Malabry, France.
| | - Claudie Bourgaux
- Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 92296 Châtenay-Malabry, France.
| | - Patrick Couvreur
- Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 92296 Châtenay-Malabry, France.
| |
Collapse
|
9
|
Chen J, Zhang X, Millican R, Sherwood J, Martin S, Jo H, Yoon YS, Brott BC, Jun HW. Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis. Adv Drug Deliv Rev 2021; 170:142-199. [PMID: 33428994 PMCID: PMC7981266 DOI: 10.1016/j.addr.2021.01.005] [Citation(s) in RCA: 66] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2020] [Revised: 01/02/2021] [Accepted: 01/03/2021] [Indexed: 12/18/2022]
Abstract
Atherosclerosis is a chronic inflammatory disease driven by lipid accumulation in arteries, leading to narrowing and thrombosis. It affects the heart, brain, and peripheral vessels and is the leading cause of mortality in the United States. Researchers have strived to design nanomaterials of various functions, ranging from non-invasive imaging contrast agents, targeted therapeutic delivery systems to multifunctional nanoagents able to target, diagnose, and treat atherosclerosis. Therefore, this review aims to summarize recent progress (2017-now) in the development of nanomaterials and their applications to improve atherosclerosis diagnosis and therapy during the preclinical and clinical stages of the disease.
Collapse
Affiliation(s)
- Jun Chen
- Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, AL, United States
| | - Xixi Zhang
- Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, AL, United States
| | | | | | - Sean Martin
- Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, AL, United States
| | - Hanjoong Jo
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, United States; Division of Cardiology, Department of Medicine, Emory University, Atlanta, GA, United States
| | - Young-Sup Yoon
- Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea
| | - Brigitta C Brott
- Division of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, United States
| | - Ho-Wook Jun
- Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, AL, United States.
| |
Collapse
|
10
|
Cook A, Decuzzi P. Harnessing Endogenous Stimuli for Responsive Materials in Theranostics. ACS NANO 2021; 15:2068-2098. [PMID: 33555171 PMCID: PMC7905878 DOI: 10.1021/acsnano.0c09115] [Citation(s) in RCA: 92] [Impact Index Per Article: 30.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/01/2020] [Accepted: 02/02/2021] [Indexed: 05/04/2023]
Abstract
Materials that respond to endogenous stimuli are being leveraged to enhance spatiotemporal control in a range of biomedical applications from drug delivery to diagnostic tools. The design of materials that undergo morphological or chemical changes in response to specific biological cues or pathologies will be an important area of research for improving efficacies of existing therapies and imaging agents, while also being promising for developing personalized theranostic systems. Internal stimuli-responsive systems can be engineered across length scales from nanometers to macroscopic and can respond to endogenous signals such as enzymes, pH, glucose, ATP, hypoxia, redox signals, and nucleic acids by incorporating synthetic bio-inspired moieties or natural building blocks. This Review will summarize response mechanisms and fabrication strategies used in internal stimuli-responsive materials with a focus on drug delivery and imaging for a broad range of pathologies, including cancer, diabetes, vascular disorders, inflammation, and microbial infections. We will also discuss observed challenges, future research directions, and clinical translation aspects of these responsive materials.
Collapse
Affiliation(s)
- Alexander
B. Cook
- Laboratory of Nanotechnology
for Precision Medicine, Istituto Italiano
di Tecnologia, Via Morego
30, 16163 Genova, Italy
| | - Paolo Decuzzi
- Laboratory of Nanotechnology
for Precision Medicine, Istituto Italiano
di Tecnologia, Via Morego
30, 16163 Genova, Italy
| |
Collapse
|
11
|
Kassam HA, Bahnson EM, Cartaya A, Jiang W, Avram MJ, Tsihlis ND, Stupp SI, Kibbe MR. Pharmacokinetics and biodistribution of a collagen-targeted peptide amphiphile for cardiovascular applications. Pharmacol Res Perspect 2020; 8:e00672. [PMID: 33090704 PMCID: PMC7580710 DOI: 10.1002/prp2.672] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2020] [Revised: 09/15/2020] [Accepted: 09/16/2020] [Indexed: 01/20/2023] Open
Abstract
Atherosclerosis remains a leading cause of death and disability around the world and a major driver of health care spending. Nanomaterials have gained widespread attention due to their promising potential for clinical translation and use. We have developed a collagen-targeted peptide amphiphile (PA)-based nanofiber for the prevention of neointimal hyperplasia after arterial injury. Our goal was to characterize the pharmacokinetics and biodistribution of the collagen-targeted PA to further its advancement into clinical trials. Collagen-targeted PA was injected into the internal jugular vein of Sprague Dawley rats. PA concentrations in plasma collected at various times after injection (0 to 72 hours) were measured by liquid chromatography-tandem mass spectrometry. Pharmacokinetics of the collagen-targeted PA were characterized by a three-compartment model, with an extremely rapid apparent elimination clearance resulting in a plasma concentration decrease of more than two orders of magnitude within the first hour after injection. This rapid initial decline in plasma concentration was not due to degradation by plasma components, as collagen-targeted PA was stable in plasma ex vivo for up to 3 hours. Indeed, cellular blood components appear to be partly responsible, as only 15% of collagen-targeted PA were recovered following incubation with whole blood. Nanofibers in whole blood also adhered to red blood cells (RBCs) and were engulfed by mononuclear cells. This work highlights the unique pharmacokinetics of our collagen-targeted PA, which differ from pharmacokinetics of small molecules. Because of their targeted nature, these nanomaterials should not require sustained elevated plasma concentrations to achieve a therapeutic effect the way small molecules typically do.
Collapse
Affiliation(s)
- Hussein A. Kassam
- Department of SurgeryCenter for Nanotechnology in Drug DeliveryUniversity of North CarolinaChapel HillNCUSA
| | - Edward M. Bahnson
- Department of SurgeryCenter for Nanotechnology in Drug DeliveryUniversity of North CarolinaChapel HillNCUSA
- Department of Cell Biology and PhysiologyUniversity of North CarolinaChapel HillNCUSA
- Department of Pharmacology and McAllister Heart InstituteUniversity of North CarolinaChapel HillNCUSA
| | - Ana Cartaya
- Department of SurgeryCenter for Nanotechnology in Drug DeliveryUniversity of North CarolinaChapel HillNCUSA
- Department of Pharmacology and McAllister Heart InstituteUniversity of North CarolinaChapel HillNCUSA
| | - Wulin Jiang
- Department of SurgeryCenter for Nanotechnology in Drug DeliveryUniversity of North CarolinaChapel HillNCUSA
| | - Michael J. Avram
- Department of AnesthesiologyNorthwestern UniversityEvanstonILUSA
| | - Nick D. Tsihlis
- Department of SurgeryCenter for Nanotechnology in Drug DeliveryUniversity of North CarolinaChapel HillNCUSA
| | - Samuel I. Stupp
- Simpson Querrey InstituteNorthwestern UniversityEvanstonILUSA
- Department of ChemistryDepartment of Materials Science and EngineeringDepartment of Medicine, and Department of Biomedical EngineeringNorthwestern UniversityEvanstonILUSA
| | - Melina R. Kibbe
- Department of SurgeryCenter for Nanotechnology in Drug DeliveryUniversity of North CarolinaChapel HillNCUSA
- Department of Biomedical EngineeringUniversity of North CarolinaChapel HillNCUSA
| |
Collapse
|
12
|
Yin X, Chen Z, Chen Y, Xie Y, Xiong B, Jiang H, Zhu J. Lipidated gemini peptide amphiphiles with enhanced loading capacity and cell membrane affinity for drug delivery. Colloids Surf B Biointerfaces 2020; 195:111271. [DOI: 10.1016/j.colsurfb.2020.111271] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2020] [Revised: 07/20/2020] [Accepted: 07/21/2020] [Indexed: 12/17/2022]
|
13
|
Uchida N, Muraoka T. Current Progress in Cross-Linked Peptide Self-Assemblies. Int J Mol Sci 2020; 21:E7577. [PMID: 33066439 PMCID: PMC7589166 DOI: 10.3390/ijms21207577] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2020] [Revised: 10/06/2020] [Accepted: 10/09/2020] [Indexed: 02/07/2023] Open
Abstract
Peptide-based fibrous supramolecular assemblies represent an emerging class of biomaterials that can realize various bioactivities and structures. Recently, a variety of peptide fibers with attractive functions have been designed together with the discovery of many peptide-based self-assembly units. Cross-linking of the peptide fibers is a key strategy to improve the functions of these materials. The cross-linking of peptide fibers forming three-dimensional networks in a dispersion can lead to changes in physical and chemical properties. Hydrogelation is a typical change caused by cross-linking, which makes it applicable to biomaterials such as cell scaffold materials. Cross-linking methods, which have been conventionally developed using water-soluble covalent polymers, are also useful in supramolecular peptide fibers. In the case of peptide fibers, unique cross-linking strategies can be designed by taking advantage of the functions of amino acids. This review focuses on the current progress in the design of cross-linked peptide fibers and their applications.
Collapse
Affiliation(s)
- Noriyuki Uchida
- Department of Applied Chemistry, Graduate School of Engineering, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan
| | - Takahiro Muraoka
- Department of Applied Chemistry, Graduate School of Engineering, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan
| |
Collapse
|
14
|
Dehghani T, Panitch A. Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle. Open Biol 2020; 10:200161. [PMID: 33050789 PMCID: PMC7653352 DOI: 10.1098/rsob.200161] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2020] [Accepted: 09/22/2020] [Indexed: 02/06/2023] Open
Abstract
Severe fibrotic and thrombotic events permeate the healthcare system, causing suffering for millions of patients with inflammatory disorders. As late-state consequences of chronic inflammation, fibrosis and thrombosis are the culmination of pathological interactions of activated endothelium, neutrophils and platelets after vessel injury. Coupling of these three cell types ensures a pro-coagulant, cytokine-rich environment that promotes the capture, activation and proliferation of circulating immune cells and recruitment of key pro-fibrotic cell types such as myofibroblasts. As the first responders to sterile inflammatory injury, it is important to understand how endothelial cells, neutrophils and platelets help create this environment. There has been a growing interest in this intersection over the past decade that has helped shape the development of therapeutics to target these processes. Here, we review recent insights into how neutrophils, platelets and endothelial cells guide the development of pathological vessel repair that can also result in underlying tissue fibrosis. We further discuss recent efforts that have been made to translate this knowledge into therapeutics and provide perspective as to how a compound or combination therapeutics may be most efficacious when tackling fibrosis and thrombosis that is brought upon by chronic inflammation.
Collapse
Affiliation(s)
| | - Alyssa Panitch
- Department of Biomedical Engineering, University of California, Davis, 451 Health Sciences Drive, GBSF 2303, Davis, CA, USA
| |
Collapse
|
15
|
Sasselli IR, Syrgiannis Z. Small Molecules Organic Co‐Assemblies as Functional Nanomaterials. European J Org Chem 2020. [DOI: 10.1002/ejoc.202000529] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Ivan R. Sasselli
- Center for Cooperative Research in Biomaterials (CIC biomaGUNE) Basque Research and Technology Alliance (BRTA) Paseo de Miramon 182 20014 Donostia San Sebastián Spain
| | - Zois Syrgiannis
- Centre of Excellence for Nanostructured Materials (CENMAT) INSTM, unit of Trieste, Dipartimento di Scienze Chimiche e Farmaceutiche Università di Trieste via L. Giorgieri 1 34127 Trieste Italy
- Simpson Querrey Institute Northwestern University 303 East Superior Street 60611 Chicago IL USA
| |
Collapse
|
16
|
|
17
|
Kassam HA, Gillis DC, Dandurand BR, Karver MR, Tsihlis ND, Stupp SI, Kibbe MR. Development of Fractalkine-Targeted Nanofibers that Localize to Sites of Arterial Injury. NANOMATERIALS 2020; 10:nano10030420. [PMID: 32121105 PMCID: PMC7152859 DOI: 10.3390/nano10030420] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/30/2019] [Revised: 02/25/2020] [Accepted: 02/26/2020] [Indexed: 12/22/2022]
Abstract
Atherosclerosis is the leading cause of death and disability around the world, with current treatments limited by neointimal hyperplasia. Our goal was to synthesize, characterize, and evaluate an injectable, targeted nanomaterial that will specifically bind to the site of arterial injury. Our target protein is fractalkine, a chemokine involved in both neointimal hyperplasia and atherosclerosis. We showed increased fractalkine staining in rat carotid arteries 24 h following arterial injury and in the aorta of low-density lipoprotein receptor knockout (LDLR-/-) mice fed a high-fat diet for 16 weeks. Three peptide amphiphiles (PAs) were synthesized: fractalkine-targeted, scrambled, and a backbone PA. PAs were ≥90% pure on liquid chromatography/mass spectrometry (LCMS) and showed nanofiber formation on transmission electron microscopy (TEM). Rats systemically injected with fractalkine-targeted nanofibers 24 h after carotid artery balloon injury exhibited a 4.2-fold increase in fluorescence in the injured artery compared to the scrambled nanofiber (p < 0.001). No localization was observed in the non-injured artery or with the backbone nanofiber. Fluorescence of the fractalkine-targeted nanofiber increased in a dose dependent manner and was observed for up to 48 h. These data demonstrate the presence of fractalkine after arterial injury and the localization of our fractalkine-targeted nanofiber to the site of injury and serve as the foundation to develop this technology further.
Collapse
Affiliation(s)
- Hussein A. Kassam
- Department of Surgery, Center for Nanotechnology in Drug Delivery, University of North Carolina, Chapel Hill, NC 27599, USA; (H.A.K.); (D.C.G.); (B.R.D.); (N.D.T.)
| | - David C. Gillis
- Department of Surgery, Center for Nanotechnology in Drug Delivery, University of North Carolina, Chapel Hill, NC 27599, USA; (H.A.K.); (D.C.G.); (B.R.D.); (N.D.T.)
| | - Brooke R. Dandurand
- Department of Surgery, Center for Nanotechnology in Drug Delivery, University of North Carolina, Chapel Hill, NC 27599, USA; (H.A.K.); (D.C.G.); (B.R.D.); (N.D.T.)
| | - Mark R. Karver
- Simpson Querrey Institute, Northwestern University, Chicago, IL 60611, USA; (M.R.K.); (S.I.S.)
| | - Nick D. Tsihlis
- Department of Surgery, Center for Nanotechnology in Drug Delivery, University of North Carolina, Chapel Hill, NC 27599, USA; (H.A.K.); (D.C.G.); (B.R.D.); (N.D.T.)
| | - Samuel I. Stupp
- Simpson Querrey Institute, Northwestern University, Chicago, IL 60611, USA; (M.R.K.); (S.I.S.)
- Department of Chemistry, Northwestern University, Evanston, IL 60208, USA
- Department of Materials Science and Engineering, Northwestern University, Evanston, IL 60208, USA
- Department of Biomedical Engineering, Northwestern University, Evanston, IL 60208, USA
- Department of Medicine, Northwestern University, Chicago, IL 60611, USA
| | - Melina R. Kibbe
- Department of Surgery, Center for Nanotechnology in Drug Delivery, University of North Carolina, Chapel Hill, NC 27599, USA; (H.A.K.); (D.C.G.); (B.R.D.); (N.D.T.)
- Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC 27599, USA
- Correspondence: ; Tel.: +001-919-445-0369
| |
Collapse
|
18
|
Sis MJ, Webber MJ. Drug Delivery with Designed Peptide Assemblies. Trends Pharmacol Sci 2019; 40:747-762. [DOI: 10.1016/j.tips.2019.08.003] [Citation(s) in RCA: 43] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2019] [Revised: 08/07/2019] [Accepted: 08/08/2019] [Indexed: 12/18/2022]
|
19
|
Nanotherapies for Treatment of Cardiovascular Disease: A Case for Antioxidant Targeted Delivery. CURRENT PATHOBIOLOGY REPORTS 2019; 7:47-60. [PMID: 31396435 DOI: 10.1007/s40139-019-00196-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Purpose of Review Cardiovascular disease (CVD) involves a broad range of clinical manifestations resulting from a dysfunctional vascular system. Overproduction of reactive oxygen and nitrogen species are causally implicated in the severity of vascular dysfunction and CVD. Antioxidant therapy is an attractive avenue for treatment of CVD associated pathologies. Implementation of targeted nano-antioxidant therapies has the potential to overcome hurdles associated with systemic delivery of antioxidants. This review examines the currently available options for nanotherapeutic targeting CVD, and explores successful studies showcasing targeted nano-antioxidant therapy. Recent Findings Active targeting strategies in the context of CVD heavily focus on immunotargeting to inflammatory markers like cell adhesion molecules, or to exposed extracellular matrix components. Targeted antioxidant nanotherapies have found success in pre-clinical studies. Summary This review underscores the potential of targeted nanocarriers as means of finding success translating antioxidant therapies to the clinic, all with a focus on CVD.
Collapse
|
20
|
Serrano CM, Freeman R, Godbe J, Lewis JA, Stupp SI. DNA-Peptide Amphiphile Nanofibers Enhance Aptamer Function. ACS APPLIED BIO MATERIALS 2019; 2:2955-2963. [PMID: 32999996 DOI: 10.1021/acsabm.9b00310] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
The single stranded DNA oligonucleotides known as aptamers have the capacity to bind proteins and other molecules and offer great therapeutic potential. Further work is required to optimize their function and to diminish their susceptibility to nuclease degradation. We report here on the synthesis and supramolecular self-assembly of DNA-peptide amphiphiles that form high aspect ratio nanofibers and display aptamers for platelet-derived growth factor. The nanofibers were found to bind the growth factor with an affinity that was fivefold greater than the free aptamer. We also observed that the aptamer displayed by the supramolecular nanostructures was eight times more nuclease resistant than free aptamer. In order to highlight the therapeutic potential of these supramolecular systems, we demonstrated the improved inhibition of proliferation when the growth factor was bound to aptamers displayed by the nanofibers.
Collapse
Affiliation(s)
- Christopher M Serrano
- Department of Materials Science and Engineering, Northwestern University, 2220 Campus Drive, Evanston, Illinois 60208, USA.,Simpson Querrey Institute, Northwestern University, 303 East Superior Street, Chicago, Illinois 60611, USA
| | - Ronit Freeman
- Simpson Querrey Institute, Northwestern University, 303 East Superior Street, Chicago, Illinois 60611, USA
| | - Jacqueline Godbe
- Simpson Querrey Institute, Northwestern University, 303 East Superior Street, Chicago, Illinois 60611, USA.,Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, USA
| | - Jacob A Lewis
- Simpson Querrey Institute, Northwestern University, 303 East Superior Street, Chicago, Illinois 60611, USA.,Department of Biomedical Engineering, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, USA
| | - Samuel I Stupp
- Department of Materials Science and Engineering, Northwestern University, 2220 Campus Drive, Evanston, Illinois 60208, USA.,Simpson Querrey Institute, Northwestern University, 303 East Superior Street, Chicago, Illinois 60611, USA.,Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, USA.,Department of Biomedical Engineering, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, USA.,Department of Medicine, Northwestern University, 676 North Saint Clair Street, Chicago, Illinois 60611, United States
| |
Collapse
|
21
|
Mansukhani NA, Peters EB, So MM, Albaghdadi MS, Wang Z, Karver MR, Clemons TD, Laux JP, Tsihlis ND, Stupp SI, Kibbe MR. Peptide Amphiphile Supramolecular Nanostructures as a Targeted Therapy for Atherosclerosis. Macromol Biosci 2019; 19:e1900066. [PMID: 31066494 PMCID: PMC6579116 DOI: 10.1002/mabi.201900066] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2019] [Revised: 04/15/2019] [Accepted: 04/18/2019] [Indexed: 12/13/2022]
Abstract
The rising prevalence of cardiovascular disease worldwide necessitates novel therapeutic approaches to manage atherosclerosis. Intravenously administered nanostructures are a promising noninvasive approach to deliver therapeutics that reduce plaque burden. The drug liver X receptor agonist GW3965 (LXR) can reduce atherosclerosis by promoting cholesterol efflux from plaque but causes liver toxicity when administered systemically at effective doses, thus preventing its clinical use. The ability of peptide amphiphile nanofibers containing apolipoprotein A1-derived targeting peptide 4F to serve as nanocarriers for LXR delivery (ApoA1-LXR PA) in vivo is investigated here. These nanostructures are found to successfully target atherosclerotic lesions in a mouse model within 24 h of injection. After 8 weeks of intravenous administration, the nanostructures significantly reduce plaque burden in both male and female mice to a similar extent as LXR alone in comparison to saline-treated controls. Furthermore, they do not cause increased liver toxicity in comparison to LXR treatments, which may be related to more controlled release by the nanostructure. These findings demonstrate the potential of supramolecular nanostructures as safe, effective drug nanocarriers to manage atherosclerosis.
Collapse
Affiliation(s)
- Neel A. Mansukhani
- Division of Vascular Surgery, Department of Surgery, Feinberg School of Medicine, 251 East Huron St., Galter 3-150, Northwestern University, Chicago, IL 60611, USA
- Simpson Querrey Institute, 303 E. Superior, Suite 11-131, Northwestern University, Chicago, IL 60611, USA
| | - Erica B. Peters
- Department of Surgery, 3001 Burnett-Womack Building, 101 Manning Drive, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Miranda M. So
- Simpson Querrey Institute, 303 E. Superior, Suite 11-131, Northwestern University, Chicago, IL 60611, USA
- Department of Materials Science and Engineering, McCormick School of Engineering and Applied Science, 2220 Campus Drive, Room 2036, Northwestern University, Evanston, IL 60208, USA
| | - Mazen S. Albaghdadi
- Division of Vascular Surgery, Department of Surgery, Feinberg School of Medicine, 251 East Huron St., Galter 3-150, Northwestern University, Chicago, IL 60611, USA
- Simpson Querrey Institute, 303 E. Superior, Suite 11-131, Northwestern University, Chicago, IL 60611, USA
| | - Zheng Wang
- Division of Vascular Surgery, Department of Surgery, Feinberg School of Medicine, 251 East Huron St., Galter 3-150, Northwestern University, Chicago, IL 60611, USA
- Simpson Querrey Institute, 303 E. Superior, Suite 11-131, Northwestern University, Chicago, IL 60611, USA
| | - Mark R. Karver
- Simpson Querrey Institute, 303 E. Superior, Suite 11-131, Northwestern University, Chicago, IL 60611, USA
| | - Tristan D. Clemons
- Simpson Querrey Institute, 303 E. Superior, Suite 11-131, Northwestern University, Chicago, IL 60611, USA
- Department of Chemistry, 2145 N. Sheridan Rd., Tech K148, Northwestern University, Evanston, IL 60208, USA
| | - Jeffrey P. Laux
- Biostatistics, Epidemiology and Research Design, NC Translational and Clinical Sciences Institute, University of North Carolina, Chapel Hill, NC 27599-7420
| | - Nick D. Tsihlis
- Division of Vascular Surgery, Department of Surgery, Feinberg School of Medicine, 251 East Huron St., Galter 3-150, Northwestern University, Chicago, IL 60611, USA
- Simpson Querrey Institute, 303 E. Superior, Suite 11-131, Northwestern University, Chicago, IL 60611, USA
- Department of Surgery, 3001 Burnett-Womack Building, 101 Manning Drive, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Samuel I. Stupp
- Simpson Querrey Institute, 303 E. Superior, Suite 11-131, Northwestern University, Chicago, IL 60611, USA
- Department of Materials Science and Engineering, McCormick School of Engineering and Applied Science, 2220 Campus Drive, Room 2036, Northwestern University, Evanston, IL 60208, USA
- Department of Chemistry, 2145 N. Sheridan Rd., Tech K148, Northwestern University, Evanston, IL 60208, USA
- Department of Medicine, 676 N. St. Clair St., Arkes Suite 2330, Northwestern University, Chicago, IL 60611, USA
- Department of Biomedical Engineering, 2145 N. Sheridan Rd., Technological Institute, Northwestern University, Evanston, IL 60208, USA
| | - Melina R. Kibbe
- Division of Vascular Surgery, Department of Surgery, Feinberg School of Medicine, 251 East Huron St., Galter 3-150, Northwestern University, Chicago, IL 60611, USA
- Simpson Querrey Institute, 303 E. Superior, Suite 11-131, Northwestern University, Chicago, IL 60611, USA
- Department of Surgery, 3001 Burnett-Womack Building, 101 Manning Drive, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
- Department of Bioengineering, 333 South Columbia Street, University of North Carolina, Chapel Hill, NC, 27514, USA
| |
Collapse
|
22
|
Booth R, Insua I, Bhak G, Montenegro J. Self-assembled micro-fibres by oxime connection of linear peptide amphiphiles. Org Biomol Chem 2019; 17:1984-1991. [PMID: 30387798 DOI: 10.1039/c8ob02243g] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Linear peptide amphiphiles are excellent biocompatible scaffolds for the hierarchical self-assembly of one-dimensional nano-structures in aqueous media. However, their structural exploration and screening of self-assembling properties are often limited by time-consuming synthesis and purification steps. We here describe the application of an oxime bond as a powerful synthetic tool towards the conjugation of peptide heads bearing a hydroxylamine group with hydrophobic aldehyde tails. This methodology allowed the quick preparation of a small library of oxime-connected peptide amphiphiles, whose supramolecular screening revealed nano-to-micro-fibrillation with dependency on their chemical structure. These results demonstrate the simplicity and the synthetic potential of the oxime conjugation for the preparation of peptide amphiphiles with improved self-assembling capabilities.
Collapse
Affiliation(s)
- Richard Booth
- Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), Departamento de Química Orgánica, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
| | | | | | | |
Collapse
|
23
|
Peters EB, Tsihlis ND, Karver MR, Chin SM, Musetti B, Ledford BT, Bahnson EM, Stupp SI, Kibbe MR. Atheroma Niche-Responsive Nanocarriers for Immunotherapeutic Delivery. Adv Healthc Mater 2019; 8:e1801545. [PMID: 30620448 PMCID: PMC6367050 DOI: 10.1002/adhm.201801545] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2018] [Revised: 12/24/2018] [Indexed: 11/12/2022]
Abstract
Nanomedicine is a promising, noninvasive approach to reduce atherosclerotic plaque burden. However, drug delivery is limited without the ability of nanocarriers to sense and respond to the diseased microenvironment. In this study, nanomaterials are developed from peptide amphiphiles (PAs) that respond to the increased levels of matrix metalloproteinases 2 and 9 (MMP2/9) or reactive oxygen species (ROS) found within the atherosclerotic niche. A pro-resolving therapeutic, Ac2-26, derived from annexin-A1 protein, is tethered to PAs using peptide linkages that cleave in response to MMP2/9 or ROS. By adjusting the molar ratios and processing conditions, the Ac2-26 PA can be co-assembled with a PA containing an apolipoprotein A1-mimetic peptide to create a targeted, therapeutic nanofiber (ApoA1-Ac226 PA). The ApoA1-Ac2-26 PAs demonstrate release of Ac2-26 within 24 h after treatment with MMP2 or ROS. The niche-responsive ApoA1-Ac2-26 PAs are cytocompatible and reduce macrophage activation from interferon gamma and lipopolysaccharide treatment, evidenced by decreased nitric oxide production. Interestingly, the linkage chemistry of ApoA1-Ac2-26 PAs significantly affects macrophage uptake and retention. Taken together, these findings demonstrate the potential of PAs to serve as an atheroma niche-responsive nanocarrier system to modulate the inflammatory microenvironment, with implications for atherosclerosis treatment.
Collapse
Affiliation(s)
- Erica B. Peters
- Department of Surgery, Division of Vascular Surgery and Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill Chapel Hill, NC 27599, USA
| | - Nick D. Tsihlis
- Department of Surgery, Division of Vascular Surgery and Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill Chapel Hill, NC 27599, USA
| | - Mark R. Karver
- Simpson Querrey Institute, Northwestern University, Chicago, IL 60611, USA
| | - Stacey M. Chin
- Department of Chemistry, Northwestern University, Evanston, IL 60208, USA
| | - Bruno Musetti
- Institute of Biological Chemistry, Universidad de la República, Montevideo, 11400, Uruguay
| | - Benjamin T. Ledford
- Department of Surgery, Division of Vascular Surgery and Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill Chapel Hill, NC 27599, USA
| | - Edward M. Bahnson
- Department of Surgery, Division of Vascular Surgery and Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill Chapel Hill, NC 27599, USA
- Department of Cell Biology & Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Samuel I. Stupp
- Simpson Querrey Institute, Northwestern University, Chicago, IL 60611, USA
- Department of Chemistry, Northwestern University, Evanston, IL 60208, USA
- Department of Materials Science & Engineering and Department of Biomedical Engineering, Northwestern University, Evanston, IL 60208, USA
- Department of Medicine, Northwestern University, Chicago, IL 60611, USA
| | - Melina R. Kibbe
- Department of Surgery, Division of Vascular Surgery and Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill Chapel Hill, NC 27599, USA
- Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| |
Collapse
|